ClinConnect ClinConnect Logo
Search / Trial NCT04034732

MBRP on Reducing Craving and Addictive Behaviour in Adults

Launched by CHINESE UNIVERSITY OF HONG KONG · Jul 25, 2019

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Mindfulness Based Intervention Mindfulness Relapse Prevention

ClinConnect Summary

This clinical trial is investigating a program called Mindfulness-Based Relapse Prevention (MBRP) to see if it can help adults in Hong Kong who struggle with substance abuse. The study aims to find out if this mindfulness approach can reduce cravings, improve mood, and enhance overall quality of life for participants. MBRP is an eight-week course that teaches skills to manage difficult feelings and situations without turning to drugs. Since mindfulness is already widely accepted and practiced in many communities, it could be a helpful and low-stigma option for those seeking support.

To be eligible for this trial, participants must be fluent in Cantonese, have received a substance use disorder diagnosis, and have completed treatment for substance abuse in the last six months. However, individuals with certain serious mental health issues or those at immediate risk of self-harm cannot participate. Those who join can expect to learn valuable mindfulness techniques in a group setting, which they can use even after the course ends to manage triggers and cravings. The study is currently recruiting participants and hopes to gather important insights on how mindfulness can support recovery from substance use disorders.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Fluent in Cantonese;
  • Has ever fulfilled the Structured Clinical Interview for DSM-IV/DSM-5 (SCID) drug module criteria for substance use disorder diagnoses; and
  • Has completed outpatient or inpatient treatment for substance abuse in the previous 6 months.
  • Exclusion Criteria:
  • Inability to provide valid consent;
  • Current or lifetime psychotic disorder assessed by the Structured Clinical interview for DSM-IV/DSM-5;
  • Imminent suicidal risk; or
  • Dementia.

About Chinese University Of Hong Kong

The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.

Locations

Hong Kong, , Hong Kong

Hong Kong, , Hong Kong

Hong Kong, , Hong Kong

Hong Kong, , Hong Kong

Hong Kong, , Hong Kong

Hong Kong, , Hong Kong

Hong Kong, , Hong Kong

Hong Kong, , Hong Kong

Hong Kong, , Hong Kong

Patients applied

0 patients applied

Trial Officials

Samuel YS Wong

Principal Investigator

JCSPHPC, CUHK

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials